Physical functioning and aging
In the table below, entries in the left column refer to the related documentation, while the values in the cells of columns LASA-B to LASA-J refer to the corresponding LASA-data files
(e.g. '161' in column B refers to:
'LASAB161'). Underlined entries are hyperlinks, hovering with your mouse over the underlined waves will show you the years in which the corresponding measurements took place.
In case entries are preceeded by 'o', the corresponding files are related to the OSTEOPOR-dataset (e.g. o80 refers to 'LASAo80'). Likewise, prefixes 'g', 'z', 'zo(a)', 'zh', 'ch', and 'zd' refer to other special datasets, more information will follow.
UC: Under Construction.
More details about the LASA-waves, see LASA-introduction.
Note that some of the data are not yet available (in red).
LASA-wave | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cohort 1 |
xxxx | xxxx | xxxx | |||||||||
Cohort 2 |
xxxx | xxxx | xxxx | xxxx | ||||||||
Cohort 3 |
xxxx | xxxx | xxxx | |||||||||
Migrant Cohort | xxxx | xxxx | ||||||||||
Blood pressure | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Blood pressure / pulse - retests |
151 - |
151 - |
151 - |
151 - |
151 151 |
151 - |
151 151 |
151 151 |
151 151 |
151 - |
151 151 |
151 151 |
Body composition | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Anthropometry - Weight and height - Calf measurement - Ankle, Knee and Pulse width |
161 161 171 - |
161 161 - 185 |
161 161 171 - |
161 161 171 - |
161 161 171 - |
161 161 171 - |
161 161 171 - |
161 161 171 - |
161 161 171 - |
161 161 - - |
161 161 161 - |
161 161 161 - |
Weight and height history; weight changeIM - tel. respondent* |
160 - |
160 - |
160 - |
160 - |
160 - |
160 - |
160 - |
160 - |
160 - |
160 - |
160 714 |
160 714 |
Bio-electrical impedance** (subsample) |
172 | - | - | - | - | - | - | - | - | - | - | - |
Birth weight | - | - | - | 134 | 134 | - | - | - | 134 | - | - | - |
Perceived body shape** - scaled |
- - |
- - |
- - |
- - |
- - |
145 345 |
145 345 |
- - |
145 345 |
145 345 |
- - |
- - |
DXA (LASA side study) - Whole body scan |
- - |
o41 o42 |
o41 o42 |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
Chronic diseases | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Chronic diseases (self-report)IM - nr. of diseases reported - tel. proxy* - tel. respondent* - longitudinally cleanedIM |
035 235 - - 435 |
035 235 602 602 435 |
035 235 602 702 - |
035 235 602 702 - |
035 235 - - - |
035 235 602 702 - |
035 235 602 702 - |
035 235 602 702 - |
035 235 - - - |
035 235 - - - |
035 235 602 702 - |
035 235 602 702 - |
GP information - data - non-response |
g01 - |
g01 g00 |
- - |
g01 g00 |
g01 g00 |
g01 g00 |
- - |
g01 g00 |
g01 g00 |
- - |
- - |
- - |
Aortic calcification (lateral radiographs) |
- | zo22 | zo22 | - | - | - | - | - | - | - | - | - |
Diabetes Mellitus (algorithm) | zdc1 | zdc1 | zdc1 | zdc1 | - zdc2 |
zdc1 zdc2 |
zdc1 zdc2 |
zdc1 zdc2 |
- - zdc3 |
- - - |
zdc1 zdc2 zdc3 |
p.m. |
Rheumatoid Arthritis (algorithm) | - | UC | - | - | - | - | - | - | - | - | - | - |
Osteoarthritis hip and knee
(algorithm) |
zoa1 - - |
zoa1 - - |
zoa1 - - |
zoa1 - - |
- zoa1 - |
zoa1 zoa2 - |
zoa1 zoa2 - |
zoa1 zoa2 - |
- - zoa3 |
- - - |
zoa1 zoa2 zoa3 |
p.m. |
Metabolic syndrome | - | ch02 | - | - | - | - | - | - | - | - | - | - |
Allostatic Load (algorithm) | - | X | - | - | - | - | - | - | - | - | - | - |
Cardiovascular diseases (algorithm) |
zh01 | zh01 | zh01 | - | - | - | - | - | - | - | - | - |
Parkinson: early P. related signs** | - | - | - | - | - | - | - | - | 096 | 096 | - | - |
Decubitus (bedsores) | 116 159 |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
Hyperthyroidism** | - | 182 | 182 | - | - | - | - | - | - | - | - | - |
Back pain | - | 182 | 182 | 182 | - | - | - | - | - | - | - | - |
Bedridden | - | 182 | 182 | - | - | 182 | 182 | 182 | 182 | - | - | - |
Fertility | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Fertility (women) | 119 | 1811 | - | - | 181 | - | - | - | 181 | 181 | - | - |
Falling | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Falls
- tel. proxy* - tel. respondent* - Falls last year |
- - - |
605 605 187 |
605 705 187 |
- - - |
- - - |
- - - |
- - - |
- - - |
- - 187 |
- - 187 |
- - - |
- - 187 |
Falls: circumstances and consequences | - | - | 187 | - | - | - | - | - | - | - | - | - |
Falls: environmental conditions (home)** |
- | 180 | 180 | - | - | - | - | - | - | - | - | - |
Falls: fear of falling (FES: Falls Efficacy Scale) |
- | 183 | 183 | - | - | - | - | - | - | - | - | - |
Falls: prevention of fall accidents (LASA side study) |
- | - | X | - |
- | - |
- |
- |
- |
- |
- | - |
Falls: 3 yr prospective fall calendar (LASA side study) | - | X | - | - | - | - | - | - | - | - | - | - |
Falls: 1 yr prospective fall calendar (LASA side study) | - | - | - | - | - | - | X | - | - | - | - | - |
DizzinessIM | - | 187 | 187 | - | 187 | 187 | 187 | 187 | 187 | - | 187 | 187 |
Adjustments and walking aids** | - | - | 187 | 187 | 187 | 187 | 187 | 187 | 187 | - | - | - |
Foot problems | - | 185 | 185 | 185 | - | 185 | - | - | - | - | - | - |
Fractures | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Fractures - total waves b-f - tel. proxy* - tel. respondent* |
zo13 - - |
zo13 |
zo13 |
zo13 |
zo13 - - |
zo13 |
- |
- |
- - - |
- - - |
- |
- 605 705 |
Vertebral deformities | - | zo22 | zo22 | - | - | - | - | - | - | - | - | - |
Quantitative ultrasound of bone | - | o31 | - | - | - | - | o31 | - | - | - | - | - |
Frailty | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Various definitions (e.g., frailty phenotype, frailty index) |
X | X |
X |
X |
X |
X |
X |
X | X | X | X | X |
Lifestyle | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Alcohol useIM | 153 353 |
153 353 |
153 353 |
153 353 |
153 353 |
153 353 |
153 353 |
153 353 |
153 353 |
153 353 |
153 353 |
153 353 |
Nutrition and Food-related
|
118 - - |
118 184 - |
118 184 - |
- - - |
- - - |
- - X |
- - - |
118 - - |
- - - |
- - - |
118 - - |
118 - - |
Oral health | - | - | - | - | - | X2 | - | - | - | - | 126 | 126 |
Physical activityIM | 046 | 046 | 046 | 046 | 046 | 046 | 046 | 046 | 046 | 046 | 046 | 046 |
Daily physical activity** | - | - | - | - | - | - | - | - | - | - | - | 162 |
Early life physical activity | - | 246 | - | - | - | - | - | - | - | - | - | - |
Perceived physical activity (LIVAS) - scaled |
114 314 |
114 314 |
114 314 |
114 314 |
114 314 |
114 314 |
- - |
- - |
- - |
- - |
- - |
- - |
Accelerometry (side studies) - subsample (Study 1) - subsample (Study 3) - subsample (Study 4) |
- - |
- - |
- - |
- - |
- - |
X2 - |
- - |
- X |
- - |
- - |
- - |
|
Sedentary behavior - scaled - scaled |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
101 301 501 |
101 301 - |
101 301 - |
101 301 - |
101 301 - |
101 301 - |
SmokingIM | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 | 154 |
Medication/supplements | B | C | D | E | 2B | F | G | H | 3B | MB | I4 | J |
Medication and food supplement use - types of medication |
152 352 |
152 352 |
152 352 |
152 352 |
152 352 |
152 352 |
152 352 |
152 352 |
152 352 |
152 352 |
152 352 |
152 352 |
Food supplement use - Vitamin D use included |
- | - | - | - | - | - | - | - | - | - | 174 374 | 174 374 |
Pain | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Subjective painIM - scaled |
115 315 |
115 315 |
115 315 |
115 315 |
115 315 |
115 315 |
115 315 |
115 315 |
115 315 |
115 315 |
115 315 |
115 315 |
Dealing with pain** | - | - | - | 188 | - | - | - | - | - | - | - | - |
Pain drawing | - | - | - | 188 | - | - | - | - | - | - | - | - |
Perception | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Vision (self-report)IM - tel. proxy* - tel. respondent* |
- - |
- - |
- - |
031 - - |
031 604 704 |
|||||||
Visual acuity test - Vision-related quality of life |
- - |
- - |
- - |
191 192 |
- - |
191 192 |
191 192 |
191 192 |
191 - |
- - |
- - |
- - |
Vision: contrast sensitivity | 157 | 157 | 157 | 157 | 157 | 157 | - | - | - | - | - | - |
Hearing (self-report)IM - tel. proxy* - tel. respondent* |
- - |
- - |
- - |
031 - - |
031 604 704 |
|||||||
Hearing: Speech in Noise Test
(SNT) Hearing: SNT questions |
- - |
- - |
- - |
193 194 |
- - |
193 194 |
193 194 |
- - |
- - |
- - |
193 194 |
- - |
Smell (Olfactory function) | - | - | - | - | - | - | - | - | S00 S01 S02 |
S00 S01 S02 |
- | - |
Physical functioning | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
Functional limitations/Disability (ADL)IM - constructed - use of assistive devices or assistance - tel. proxy* - tel. respondent* - Limitations in joint mobility |
- |
|
|
|
- |
- |
- |
- |
- |
- |
- |
- |
Global Activity Limitations - tel. respondent* |
033 - |
033 603 |
033 703 |
033 703 |
033 - |
033 703 |
033 703 |
033 703 |
033 - |
- - |
033 703 |
033 703 |
Physical performance |
034 | 034 | 034 | 034 | 034 | 034 | 034 | 034 | 034 | 034 | 034 | 034 |
Pulmonary function test - Peak Flow |
- - |
- - |
- - |
- - |
- |
- |
- - |
- - |
- |
- |
- |
|
Grip strength | - | 161 | 161 | 161 | 161 | 161 | 161 | 161 | 161 | 161 | 161 | 161 |
Quality of life | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
EuroQol - scaled |
- - |
- - |
- - |
135 335 |
- - |
135 335 |
135 335 |
135 335 |
135 335 |
- - |
135 335 |
- - |
Qualeffo-41 - (non)response - Qualeffo scores - scaled |
|
|
|
o80 o81 o82 |
|
|
|
|
|
|
|
|
SF-12 Health Survey - scaled (Am.) |
- |
- |
- |
- |
133 533 |
|||||||
WHO Quality of Life** | - | - | - | - | - | - | - | - | - | - | 133 | 133 |
Self-rated health - GHPQ - GHPQ: scaled - tel. proxy* - tel. respondent* |
036 113 313 - - |
036 113 313 602 602 |
036 113 313 602 702 |
036 113 313 602 702 |
036 113 313 - - |
036 113 313 602 702 |
036 113 313 602 702 |
036 113 313 602 702 |
036 113 313 - - |
036 - - - - |
036 - - 602 702 |
036 - - 602 702 |
LASA-wave | B | C | D | E | 2B | F | G | H | 3B | MB | I | J |
* Files in the 700 series contain data from telephone interviews held with respondents, while files in the 600 series contain data from telephone interviews held with proxies. In wave C however, the same questionnaire was used for both respondent and proxy; data was stored in the 600 series.
** Not yet documented
1 Fertility (Women) moved from self-administered questionnaire (LASAB119) to medical interview (LASAC181 / LAS2B181 / LAS3B181 / LASMB181)
2 As part of the Lifestyle study
3 As part of the EPOSA study
4 In wave I Food supplement questions moved to LASA174
IM In 2004, three years after wave E an interim measurement was carried out on the first cohort, see the specific topics for more details. More information will follow.